AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Treatment Options for Metastatic Castrate-Resistant Prostate Cancer
This chapter discusses the various treatment options for metastatic castrate-resistant prostate cancer, including docetaxel, enzalutamide, and abiraterone with prednisone. It explores the pivotal phase 3 trials for these treatments, as well as the rationale for sequencing enzalutamide after abiraterone.